Robinson Cole LLP
High Contrast Mode
Marquee

Business Transactions in Health Care

At Robinson+Cole, we recognize the unique nature of health care transactions, especially given the ever-changing business and regulatory landscapes. We work on behalf of our clients, within applicable regulatory constraints, to structure a transaction in a manner that helps achieve their business objectives, whether those objectives are to buy a business, sell a business, form a joint venture, or start a new line of business. From initial business negotiations to post-closing operations, we work to understand each client’s business model and how each transaction helps our client succeed.

Our Health Law group is structured to bring the appropriate resources to handle all aspects of a transaction, including corporate and finance, regulatory, privacy and data protection, tax, real estate, antitrust, labor and employment, employee benefits, and intellectual property. We strive to add value by offering concise reasoning and effective, practical solutions designed to address the myriad business, legal, and regulatory issues that arise in the health care industry.

Our Services

Robinson+Cole’s full array of legal services provided to the health care industry includes:

  • Representation in mergers, acquisitions, dispositions, joint ventures, debt and equity financings, and other business transactions;
  • Representation before state and federal regulatory agencies with respect to investigations, surveys, and certification; reimbursement; certificates of need and licensure; and permit transfers and change of control;
  • Representation in civil and criminal litigation;
  • Regulatory analysis and audits for compliance with federal and state laws and regulations;
  • Development and review of compliance plans;
  • Guidance regarding Medicare, Medicaid, and private, third-party reimbursement issues;
  • Representation with respect to labor, employment, tax, and not-for-profit issues;
  • Implementation of integration strategies;
  • Compliance and internal investigations;
  • HIPAA (Health Information Portability and Accountability Act); and
  • Health information technology.

Experience


Represented The Pennant Group in Acquisition of Home Health + Hospice Operations

Led The Pennant Group’s acquisition of home health, hospice, and personal care operations across Tennessee, Georgia, and Alabama from UnitedHealth Group and Amedisys Inc. The $146.5 million deal, one of the largest homecare and hospice transactions of 2025, involved 54 locations and strategically expands Pennant’s footprint into the Southeast, including certificate-of-need states such as Tennessee, and positions the company for continued growth in challenging markets.

Read More

Represented Help at Home in Acquisition of Home Care Now of Central Florida

Represented Help at Home, a nationwide leading provider of innovative, relationship-driven, in-home personal care, in its acquisition of Home Care Now of Central Florida, a state-licensed home care agency providing personalized home health services in central Florida. The acquisition will see Help at Home expand and strengthen its Florida presence to provide home care services across every county throughout the state.

Read More
Represented Help at Home in Acquisition of Home Care Now of Central Florida

Represented Acentus in Acquisition by Henry Schein, Inc.

Served as legal counsel for Acentus, a national medical supplier specializing in the delivery of continuous glucose monitors for Medicare patients, in its acquisition by Henry Schein, Inc., a solutions company for health care professionals advising over 1 million customers globally to help improve operational success and clinical outcomes. The acquisition, which was announced on November 20, 2024, will see Henry Schein acquire substantially all of Acentus’ assets, and will expand its national homecare solutions platform to address the evolving needs of clients.

Read More
Represented Acentus in Acquisition by Henry Schein, Inc.


Publications


Health Law Diagnosis teaser
October 1, 2024

Health Law Diagnosis

January 19, 2024

Health Care Transactions and Civil Investigative Demands: What Third Parties Need to Know

Health Law Weekly

The article analyzes mergers and acquisitions (M&A) trends in health care markets, the increased scrutiny transactions face from the Federal Trade Commission and U.S. Department of Justice, Antitrust Division (collectively, the Agencies), and the Agencies’ use of civil investigate demands (CIDs) and their impact on the M&A process. “With the expected increase in health care merger activity comes the likelihood of greater investigatory scrutiny by government authorities,” they write, “Given the potentially significant implications of non-compliance or insufficient compliance, recipients of CIDs and subpoenas would do well to take those demands seriously and act promptly and comprehensively, including by engaging experienced counsel. To read the article, click here.

Legal Update: Department of Justice and State Attorneys General Pursue Private Equity Firms Under the False Claims Act teaser
December 20, 2021

Legal Update: Department of Justice and State Attorneys General Pursue Private Equity Firms Under the False Claims Act

Health Law Diagnosis teaser
October 1, 2024

Health Law Diagnosis

January 19, 2024

Health Care Transactions and Civil Investigative Demands: What Third Parties Need to Know

Health Law Weekly

The article analyzes mergers and acquisitions (M&A) trends in health care markets, the increased scrutiny transactions face from the Federal Trade Commission and U.S. Department of Justice, Antitrust Division (collectively, the Agencies), and the Agencies’ use of civil investigate demands (CIDs) and their impact on the M&A process. “With the expected increase in health care merger activity comes the likelihood of greater investigatory scrutiny by government authorities,” they write, “Given the potentially significant implications of non-compliance or insufficient compliance, recipients of CIDs and subpoenas would do well to take those demands seriously and act promptly and comprehensively, including by engaging experienced counsel. To read the article, click here.

Legal Update: Department of Justice and State Attorneys General Pursue Private Equity Firms Under the False Claims Act teaser
December 20, 2021

Legal Update: Department of Justice and State Attorneys General Pursue Private Equity Firms Under the False Claims Act

Legal Update: Paid Sick and Family Leave Legislation in Response to Coronavirus (COVID-19 Coronavirus) teaser
March 31, 2020

Legal Update: Paid Sick and Family Leave Legislation in Response to Coronavirus (COVID-19 Coronavirus)



Legal Update: Paid Sick and Family Leave Legislation in Response to Coronavirus (COVID-19 Coronavirus) teaser
March 31, 2020

Legal Update: Paid Sick and Family Leave Legislation in Response to Coronavirus (COVID-19 Coronavirus)

News


January 13, 2026

Les Levinson Shares Insight on Hospice 2026 M&A Outlook

Business Transactions in Health Care group co-chair Les Levinson spoke with Hospice News sharing his views about an anticipated M&A upswing in 2026. In the article, “The Pendulum Swings: Hospices’ 2026 M&A Outlook,” published on January 8, 2026, Les said expectations are for a more active M&A environment, although size and scale may hold less weight among buyers than quality and compliance. “Transactions of size aren’t always an accurate barometer,” of where the market is in terms of activity level said Les. “There’s still plenty of space in the $30, $40 and $50 million hospice transactions. Those are going to be more impactful over the course of 2026. The industry is still pretty fragmented and most of the transactions are going to occur in that mid-market landscape. We’ll see more purposeful, more targeted deals and less of a stampede for scale. We’re seeing more companies being broken up with multiple acquirers, which makes risk tolerance more manageable.”

Hospice News
January 6, 2026

Les Levinson Shares Insight on State of M&A Activity in Late 2025

Hospice News
December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
January 13, 2026

Les Levinson Shares Insight on Hospice 2026 M&A Outlook

Business Transactions in Health Care group co-chair Les Levinson spoke with Hospice News sharing his views about an anticipated M&A upswing in 2026. In the article, “The Pendulum Swings: Hospices’ 2026 M&A Outlook,” published on January 8, 2026, Les said expectations are for a more active M&A environment, although size and scale may hold less weight among buyers than quality and compliance. “Transactions of size aren’t always an accurate barometer,” of where the market is in terms of activity level said Les. “There’s still plenty of space in the $30, $40 and $50 million hospice transactions. Those are going to be more impactful over the course of 2026. The industry is still pretty fragmented and most of the transactions are going to occur in that mid-market landscape. We’ll see more purposeful, more targeted deals and less of a stampede for scale. We’re seeing more companies being broken up with multiple acquirers, which makes risk tolerance more manageable.”

Hospice News
January 6, 2026

Les Levinson Shares Insight on State of M&A Activity in Late 2025

Hospice News
December 18, 2025

Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala

Global M&A Network
Business Transactions in Health Care Team Wins “Pharma & Devices Deal of the Year” at Global M&A Network’s 7th Annual USA Middle Markets M&A Atlas Awards Gala teaser
October 8, 2025

Robinson+Cole Healthcare Transactions Team Represents The Pennant Group in One of 2025’s Largest Homecare and Hospice Transactions

September 9, 2025

Les Levinson Talks Interest Rates and Valuations in Q&A on Industry M&A Activity

Hospice News
August 18, 2025

Les Levinson Discusses Impact of Proposed Exemption with Home Health Care News

Home Health Care News
August 4, 2025

Les Levinson Discusses Cross-Sector M&A

Home Health Care News
July 14, 2025

Les Levinson Interviewed on 2025 M&A Outlook

CareSmartz360
May 22, 2025

Health Care Transactions Team Represents Help at Home in Acquisition of Home Care Now of Central Florida


October 8, 2025

Robinson+Cole Healthcare Transactions Team Represents The Pennant Group in One of 2025’s Largest Homecare and Hospice Transactions

September 9, 2025

Les Levinson Talks Interest Rates and Valuations in Q&A on Industry M&A Activity

Hospice News
August 18, 2025

Les Levinson Discusses Impact of Proposed Exemption with Home Health Care News

Home Health Care News
August 4, 2025

Les Levinson Discusses Cross-Sector M&A

Home Health Care News
July 14, 2025

Les Levinson Interviewed on 2025 M&A Outlook

CareSmartz360
May 22, 2025

Health Care Transactions Team Represents Help at Home in Acquisition of Home Care Now of Central Florida